387 results on '"Gheorghe, Liana"'
Search Results
2. Nonalcoholic Fatty Liver Disease Within Other Causes of Chronic Liver Diseases
3. A global research priority agenda to advance public health responses to fatty liver disease
4. THU-186 Long term risk assessment of patients with primary sclerosing cholangitis using clinical prognosis models
5. EASL Clinical Practice Guidelines on hepatitis delta virus
6. Indications for Liver Transplantation in Adults: Selection of Patients with End Stage Liver Diseases
7. Prospective study of hepatitis B and D epidemiology and risk factors in Romania: A 10-year update
8. Sylimarin Versus Essential Phospholipids in Metabolic Associated Steatotic Liver Disease (MASLD) – A Prospective Comparative Randomized Trial
9. Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective
10. A portrait of viral hepatitis in the Roma population highlighting potential disparities
11. A New Dawn in Hepatitis D Management.
12. Metabolic-associated fatty liver disease in socio-economic vulnerable population with chronic hepatitis B and C
13. Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of Lonafarnib-boosted with Ritonavir with or without Peginterferon Alfa in patients with chronic hepatitis delta
14. Fatigue Is Associated with Anxiety and Lower Health-Related Quality of Life in Patients with Inflammatory Bowel Disease in Remission
15. Pre and post-liver transplant outcome of cirrhotic patients with acute on chronic liver failure
16. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
17. Real World Efficacy and Safety of Sofosbuvir + Velpatasvir + Voxilaprevir in Romanian Patients with Genotype 1b HCV Infection Non-reponders to DAAs Therapy
18. Host and immunosuppression-related factors influencing fibrosis occurrence post liver transplantation
19. Atypical Immunohistochemistry Features in an AFP-producing Colon Cancer
20. Editorial: Sarcopenia, Frailty and Nutrition in Liver Diseases
21. Predictive Factors for Death on a Long Waiting List for Liver Transplantation after an Episode of Acute on Chronic Liver Failure
22. The risks of hepatocellular carcinoma and variceal bleeding after HCV eradication with direct-acting antiviral therapy: a propensity score analysis
23. Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older
24. An international survey on patterns of practice in NAFLD and expectations for therapies—The POP‐NEXT project
25. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
26. Health-Related Quality of Life in Patients with Inflammatory Bowel Disease in Clinical Remission: What Should We Look For?
27. Do the needle type and the operator experience influence liver biopsy specimen quality?
28. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
29. Mutation analysis of the ATP7B gene in a new group of Wilson's disease patients: Contribution to diagnosis
30. Assessment of Sarcopenia Related Quality of Life Using SarQoL® Questionnaire in Patients With Liver Cirrhosis
31. The Predictive Role of Variceal Band Ligation in the Development of Portal Vein Thrombosis in Cirrhotic Patients
32. Genetic and Life Style Risk Factors for Recurrent Non-alcoholic Fatty Liver Disease Following Liver Transplantation
33. Reply to “Anticoagulant treatment in cirrhotic portal vein thrombosis –how wide can we open the window?”
34. Anticoagulation Therapy for Portal Vein Thrombosis in Patients with Cirrhosis in a Tertiary Center Experience
35. Diagnostic Delay in Romanian Patients with Inflammatory Bowel Disease: Risk Factors and Impact on the Disease Course and Need for Surgery
36. Risk Factors for Extraintestinal Manifestations in Inflammatory Bowel Diseases - Data from the Romanian National Registry
37. Long Term Follow-up of Liver Transplant Recipients: Considerations for Non-transplant Specialists
38. Advancing the global public health agenda for NAFLD: a consensus statement
39. GAVE: a gastroenterologist challenge
40. Normal histology, the new target for ulcerative colitis treatment, might not be the cure
41. FRI-150 - Metabolic-associated fatty liver disease in socio-economic vulnerable population with chronic hepatitis B and C
42. GS-012 - Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of Lonafarnib-boosted with Ritonavir with or without Peginterferon Alfa in patients with chronic hepatitis delta
43. The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries
44. Impact of Sustained Virological Response on Metabolic Profile and Kidney Function in Cured HCV Liver Transplant Recipients
45. COVID-19 in Liver Transplant Candidates: Pre- and Post-Transplant Outcome
46. A Combined Program of Cadaveric and Living-Related Liver Transplantation in a Single Center: An Experience of 1,000 Operations
47. The Prevalence of HCV Infection and Risk Factors in a Hospital- Based Population Screening, a First Step to the Micro-Elimination of HCV Infection in Medical Institutions from Romania - Results of the HepC ALERT Study
48. Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe
49. Clinical and economic consequences of antiviral treatment for hepatitis C chronic infection in Europe: analysis of England, Italy, Romania and Spain data
50. Systemic light chain AL with cardiac and liver involvement can be predicted by transient elastography
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.